Ex-Vivo Lung Perfusion - A Solution to the Lung Availability Crisis?

Many people are unaware that allocating donor organs remains to be a prominent limitation in performing transplant surgeries. The waiting list for recipients awaiting an organ has been increasing and often recipients are admitted into the hospital on life support while they wait. Ex-Vivo Lung Perfusion (EVLP) is a medical procedure that could potentially reduce wait times by modifying a donor’s lungs to improve the post-operation outcomes and overall survival rate. Dr. Steve Singh, a renowned cardiac surgeon joins the discussion to provide insight on EVLP. This video was made by McMaster students Gaurev, Arinze, Elizabeth in collaboration with the McMaster Demystifying Medicine Program. References: Fisher, A., Andreasson, A., Chrysos, A., Lally, J., Mamasoula, C., Exley, C., ... & Dark, J. (2016). An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK. Health Technology Assessment, 20(85), 1-276. Nelson, K., Bobba, C., Eren, E., Spata, T., Tadres, M., & Hayes, D. (20